Literature DB >> 14617402

The Assessing Patients' Preferred Treatments (APPT-1) study.

G Moyle1.   

Abstract

Limited information is currently available on patient preferences regarding administration frequency, tablet load and the trade-off between side effects and convenience in choosing antiretroviral regimens. A standardized questionnaire of persons with HIV infection across 5 large European countries was used to assess patient preference. 504 people with HIV participated. Participants showed a preference for once-daily therapy administration. However, several factors affected this preference.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14617402     DOI: 10.1258/095646203322491860

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  7 in total

Review 1.  Translating efficacy into effectiveness in antiretroviral therapy: beyond the pill count.

Authors:  Courtney V Fletcher
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 2.  Efficacy and safety of once-daily regimens in the treatment of HIV infection.

Authors:  Jean-Michel Molina
Journal:  Drugs       Date:  2008       Impact factor: 9.546

3.  Osteoporosis medication profile preference: results from the PREFER-US study.

Authors:  Thomas W Weiss; Colleen A McHorney
Journal:  Health Expect       Date:  2007-09       Impact factor: 3.377

4.  Evaluating patient preference and satisfaction for human immunodeficiency virus therapy in France.

Authors:  Sylvie Brégigeon-Ronot; Antoine Cheret; André Cabié; Thierry Prazuck; Alain Volny-Anne; Shehzad Ali; Catherine Bottomley; Laurent Finkielsztejn; Caroline Philippe; Jean-Jacques Parienti
Journal:  Patient Prefer Adherence       Date:  2017-07-10       Impact factor: 2.711

Review 5.  Efavirenz: a decade of clinical experience in the treatment of HIV.

Authors:  Franco Maggiolo
Journal:  J Antimicrob Chemother       Date:  2009-09-18       Impact factor: 5.790

6.  Impact of reducing dosing frequency on adherence to oral therapies: a literature review and meta-analysis.

Authors:  Kunal Srivastava; Anamika Arora; Aditi Kataria; Joseph C Cappelleri; Alesia Sadosky; Andrew M Peterson
Journal:  Patient Prefer Adherence       Date:  2013-05-20       Impact factor: 2.711

7.  Assessment of Maraviroc Exposure-Response Relationship at 48 Weeks in Treatment-Experienced HIV-1-Infected Patients in the MOTIVATE Studies.

Authors:  P Jacqmin; J R Wade; B Weatherley; E Snoeck; S Marshall; L McFadyen
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2013-08-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.